Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups

被引:101
作者
Hirose, Y
Aldape, K
Bollen, A
James, CD
Brat, D
Lamborn, K
Berger, M
Feuerstein, BG
机构
[1] Univ Calif San Francisco, Canc Genet Program, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Lab Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Div Neuropathol, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA
[6] Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[7] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
D O I
10.1016/S0002-9440(10)64061-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Ependymoma occurs most frequently within the central nervous system of children and young adults. We determined relative chromosomal copy-number aberrations in 44 ependymomas using comparative genomic hybridization, The study included 24 intracranial and 20 spinal cord tumors from pediatric and adult patients. Frequent chromosomal aberrations in intracranial tumors were gain of 1q and losses on 6q, 9, and 13, Gain of 1q and loss on 9 were preferentially associated with histological grade 3 tumors. On the other hand, gain on chromosome 7 was recognized almost exclusively in spinal cord tumors, and was associated with various other chromosomal aberrations including frequent loss of 22q. We conclude that cytogenetic analysis of ependymomas may help to classify these tumors and provide leads concerning their initiation and progression. The relationship of these aberrations to patient outcome needs to be addressed.
引用
收藏
页码:1137 / 1143
页数:7
相关论文
共 61 条
[11]   CHROMOSOME-ABNORMALITIES IN LOW-GRADE CENTRAL-NERVOUS-SYSTEM TUMORS [J].
GRIFFIN, CA ;
LONG, PP ;
CARSON, BS ;
BREM, H .
CANCER GENETICS AND CYTOGENETICS, 1992, 60 (01) :67-73
[12]   A multi-institutional retrospective study of intracranial ependymoma in children: Identification of risk factors [J].
Horn, B ;
Heideman, R ;
Geyer, R ;
Pollack, I ;
Packer, R ;
Goldwein, J ;
Tomita, T ;
Schomberg, P ;
Ater, J ;
Luchtman-Jones, L ;
Rivlin, K ;
Lamborn, K ;
Prados, M ;
Bollen, A ;
Berger, M ;
Dahl, G ;
McNeil, E ;
Patterson, K ;
Shaw, D ;
Kubalik, M ;
Russo, C .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1999, 21 (03) :203-211
[13]  
Huhn SL, 1999, CLIN CANCER RES, V5, P1435
[14]   Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2 [J].
Hulsebos, TJM ;
Oskam, NT ;
Bijleveld, EH ;
Westerveld, A ;
Hermsen, MA ;
van den Ouweland, AMW ;
Hamel, BC ;
Tijssen, CC .
BRITISH JOURNAL OF CANCER, 1999, 81 (07) :1150-1154
[15]   INTRACRANIAL EPENDYMOMAS IN CHILDHOOD - A REPORT OF 24 CASES FOLLOWED FOR 5 YEARS [J].
JAYAWICKREME, DP ;
HAYWARD, RD ;
HARKNESS, WFJ .
CHILDS NERVOUS SYSTEM, 1995, 11 (07) :409-413
[16]  
Kamb A, 1994, Nat Genet, V8, P23
[17]   CHROMOSOMAL-ABNORMALITIES IN GLIOBLASTOMA-MULTIFORME TUMORS AND GLIOMA CELL-LINES DETECTED BY COMPARATIVE GENOMIC HYBRIDIZATION [J].
KIM, DH ;
MOHAPATRA, G ;
BOLLEN, A ;
WALDMAN, FM ;
FEUERSTEIN, BG .
INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (06) :812-819
[18]  
Kleihues P., 1993, HISTOLOGICAL TYPING, P5
[19]   Molecular cytogenetic studies of pediatric ependymomas [J].
Kramer, DL ;
Parmiter, AH ;
Rorke, LB ;
Sutton, LN ;
Biegel, JA .
JOURNAL OF NEURO-ONCOLOGY, 1998, 37 (01) :25-33
[20]   HUMAN RETINOBLASTOMA SUSCEPTIBILITY GENE - CLONING, IDENTIFICATION, AND SEQUENCE [J].
LEE, WH ;
BOOKSTEIN, R ;
HONG, F ;
YOUNG, LJ ;
SHEW, JY ;
LEE, EYHP .
SCIENCE, 1987, 235 (4794) :1394-1399